US Bancorp DE Boosts Holdings in DENTSPLY SIRONA Inc. $XRAY

US Bancorp DE lifted its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 12.0% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 61,827 shares of the medical instruments supplier’s stock after purchasing an additional 6,604 shares during the quarter. US Bancorp DE’s holdings in DENTSPLY SIRONA were worth $982,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also bought and sold shares of the company. Envestnet Asset Management Inc. raised its position in DENTSPLY SIRONA by 9.0% in the 1st quarter. Envestnet Asset Management Inc. now owns 494,737 shares of the medical instruments supplier’s stock worth $7,391,000 after buying an additional 40,936 shares during the last quarter. Brown Advisory Inc. purchased a new position in DENTSPLY SIRONA in the 1st quarter worth about $679,000. Dynamic Technology Lab Private Ltd purchased a new position in DENTSPLY SIRONA in the 1st quarter worth about $366,000. Krilogy Financial LLC purchased a new position in DENTSPLY SIRONA in the 2nd quarter worth about $336,000. Finally, BFI Infinity Ltd. purchased a new position in DENTSPLY SIRONA in the 2nd quarter worth about $335,000. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Trading Down 0.9%

DENTSPLY SIRONA stock opened at $12.51 on Friday. The firm has a 50 day moving average of $13.38 and a 200 day moving average of $14.52. The firm has a market capitalization of $2.50 billion, a price-to-earnings ratio of -2.64, a P/E/G ratio of 0.79 and a beta of 0.96. DENTSPLY SIRONA Inc. has a 12-month low of $11.69 and a 12-month high of $24.86. The company has a current ratio of 1.69, a quick ratio of 1.11 and a debt-to-equity ratio of 1.13.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Thursday, August 7th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.02. The company had revenue of $936.00 million during the quarter, compared to analyst estimates of $929.67 million. DENTSPLY SIRONA had a negative net margin of 25.85% and a positive return on equity of 16.33%. The firm’s quarterly revenue was down 4.9% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.49 EPS. DENTSPLY SIRONA has set its FY 2025 guidance at 1.800-2.000 EPS. As a group, research analysts predict that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, October 10th. Shareholders of record on Friday, September 26th were paid a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 5.1%. The ex-dividend date was Friday, September 26th. DENTSPLY SIRONA’s dividend payout ratio is presently -13.50%.

Analysts Set New Price Targets

A number of equities analysts have weighed in on the company. Stifel Nicolaus decreased their target price on DENTSPLY SIRONA from $19.00 to $17.00 and set a “hold” rating for the company in a research report on Friday, August 8th. Needham & Company LLC reissued a “hold” rating on shares of DENTSPLY SIRONA in a research report on Friday, September 26th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of DENTSPLY SIRONA in a research report on Wednesday, October 8th. Evercore ISI reduced their price target on shares of DENTSPLY SIRONA from $17.00 to $13.00 and set an “in-line” rating for the company in a research report on Wednesday, October 8th. Finally, Wells Fargo & Company reduced their price target on shares of DENTSPLY SIRONA from $16.00 to $15.00 and set an “equal weight” rating for the company in a research report on Friday, August 8th. Two research analysts have rated the stock with a Buy rating, eleven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $18.00.

DENTSPLY SIRONA Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.